Literature DB >> 20174457

Effects of aging on the adaptive immune response to respiratory virus infections.

Ross B Fulton1, Steven M Varga.   

Abstract

Severe acute respiratory disease caused by respiratory virus infections in individuals aged 65 years and older and in high-risk adults, such as those with chronic cardiopulmonary disorders, is associated with increased hospitalization and mortality rates. Epidemiological studies have identified influenza virus and respiratory syncytial virus as the most frequent causes of virus-induced respiratory disease in elderly and high-risk adults. Studies in both humans and animal models have established fundamental defects in cell-mediated and humoral immune responses in aged individuals. However, it is not well understood how age specifically alters the immune response to respiratory pathogens. In this review, we will focus our discussion on the major causative agents of severe respiratory virus infections in elderly and high-risk adults and the age-associated defects in the immune response that probably contribute to the increased disease severity observed in these populations.

Entities:  

Year:  2009        PMID: 20174457      PMCID: PMC2822389          DOI: 10.2217/ahe.09.69

Source DB:  PubMed          Journal:  Aging health        ISSN: 1745-509X


  122 in total

1.  Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A.

Authors:  A Lerner; T Yamada; R A Miller
Journal:  Eur J Immunol       Date:  1989-06       Impact factor: 5.532

Review 2.  Aging and CD8+ T cell immunity to respiratory virus infections.

Authors:  Kenneth H Ely; Alan D Roberts; Jacob E Kohlmeier; Marcia A Blackman; David L Woodland
Journal:  Exp Gerontol       Date:  2007-01-02       Impact factor: 4.032

3.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

Review 4.  Immunity to respiratory viruses.

Authors:  Jacob E Kohlmeier; David L Woodland
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

5.  Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly.

Authors:  Yuping Deng; Yu Jing; Ann E Campbell; Stefan Gravenstein
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

6.  Early antigen-specific response by naive CD8 T cells is not altered with aging.

Authors:  Shaokang P Li; Zeling Cai; Weixing Shi; Anders Brunmark; Michael Jackson; Phyllis-Jean Linton
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

7.  Alterations in the human immune response to the hepatitis B vaccine among the elderly.

Authors:  J M Cook; N Gualde; L Hessel; M Mounier; J P Michel; F Denis; M H Ratinaud
Journal:  Cell Immunol       Date:  1987-10-01       Impact factor: 4.868

8.  Respiratory syncytial viral infection in children with compromised immune function.

Authors:  C B Hall; K R Powell; N E MacDonald; C L Gala; M E Menegus; S C Suffin; H J Cohen
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

9.  An outbreak of coronavirus OC43 respiratory infection in Normandy, France.

Authors:  Astrid Vabret; Thomas Mourez; Stéphanie Gouarin; Joëlle Petitjean; François Freymuth
Journal:  Clin Infect Dis       Date:  2003-04-04       Impact factor: 9.079

Review 10.  Rhinovirus and the lower respiratory tract.

Authors:  Frederick G Hayden
Journal:  Rev Med Virol       Date:  2004 Jan-Feb       Impact factor: 6.989

View more
  12 in total

1.  Increased T-bet is associated with senescence of influenza virus-specific CD8 T cells in aged humans.

Authors:  Douglas V Dolfi; Kathleen D Mansfield; Antonio M Polley; Susan A Doyle; Gordon J Freeman; Hanspeter Pircher; Kenneth E Schmader; E John Wherry
Journal:  J Leukoc Biol       Date:  2013-02-25       Impact factor: 4.962

2.  Age-related changes in the transcriptome of antibody-secreting cells.

Authors:  Senthil Kannan; Noor Dawany; Raj Kurupati; Louise C Showe; Hildegund C J Ertl
Journal:  Oncotarget       Date:  2016-03-22

3.  Retrospective Parameter Estimation and Forecast of Respiratory Syncytial Virus in the United States.

Authors:  Julia Reis; Jeffrey Shaman
Journal:  PLoS Comput Biol       Date:  2016-10-07       Impact factor: 4.475

Review 4.  Respiratory Syncytial Virus's Non-structural Proteins: Masters of Interference.

Authors:  Elena Margaret Thornhill; David Verhoeven
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

5.  Aged mice exhibit a severely diminished CD8 T cell response following respiratory syncytial virus infection.

Authors:  Ross B Fulton; Kayla A Weiss; Lecia L Pewe; John T Harty; Steven M Varga
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

6.  Respiratory syncytial virus (RSV) infection in elderly mice results in altered antiviral gene expression and enhanced pathology.

Authors:  Terianne M Wong; Sandhya Boyapalle; Viviana Sampayo; Huy D Nguyen; Raminder Bedi; Siddharth G Kamath; Martin L Moore; Subhra Mohapatra; Shyam S Mohapatra
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

7.  Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine.

Authors:  Venkateswarlu Chamcha; Sunil Kannanganat; Sailaja Gangadhara; Rafiq Nabi; Pamela A Kozlowski; David C Montefiori; Celia C LaBranche; Jens Wrammert; Brandon F Keele; Harikrishnan Balachandran; Sujata Sahu; Michelle Lifton; Sampa Santra; Rahul Basu; Bernard Moss; Harriet L Robinson; Rama Rao Amara
Journal:  Open Forum Infect Dis       Date:  2016-02-11       Impact factor: 3.835

Review 8.  Respiratory syntycial virus: Current treatment strategies and vaccine approaches.

Authors:  Elena Margret Thornhill; Jessica Salpor; David Verhoeven
Journal:  Antivir Chem Chemother       Date:  2020 Jan-Dec

Review 9.  Immunosenescence and human vaccine immune responses.

Authors:  Stephen N Crooke; Inna G Ovsyannikova; Gregory A Poland; Richard B Kennedy
Journal:  Immun Ageing       Date:  2019-09-13       Impact factor: 9.701

10.  Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.

Authors:  Pedro A Reche
Journal:  Front Immunol       Date:  2020-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.